TAY-018

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameTAY-018
Drug Alias NameTAY-018
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCluster of differentiation 47 inhibitors
TargetsCluster of differentiation 47
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTot Biopharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTot Biopharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursMyelodysplastic SyndromesLymphoma, Non-Hodgkin +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A